CSL Limited (CSL.AX)
| Previous close | 295.40 |
| Open | 299.00 |
| Bid | 293.71 x 0 |
| Ask | 294.79 x 0 |
| Day's range | 292.35 - 299.00 |
| 52-week range | 228.65 - 313.55 |
| Volume | |
| Avg. volume | 671,275 |
| Market cap | 142.589B |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 36.49 |
| EPS (TTM) | 8.07 |
| Earnings date | 13 Aug 2024 |
| Forward dividend & yield | 3.97 (1.35%) |
| Ex-dividend date | 09 Sept 2024 |
| 1y target est | 327.30 |
Simply Wall St.CSL (ASX:CSL) Gains Approval for Updated COVID-19 Vaccine in Japan, Boosting Strategic Alliances
CSL (ASX:CSL) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a 25% increase in net profit after tax and innovative product launches, juxtaposed against near-term market growth difficulties and inflationary pressures.
GlobeNewswireMark Cuban Foundation and CSL Bring Free AI Bootcamp to Philadelphia Teens
APPLICATIONS CLOSE SEPTEMBER 30PHILADELPHIA, Sept. 17, 2024 (GLOBE NEWSWIRE) -- In an era where artificial intelligence (AI) is transforming industries and reshaping our daily lives, it is more important than ever to equip the next generation with the skills and knowledge to harness these powerful tools. The Mark Cuban Foundation, in partnership with CSL, is proud to bring the only artificial intelligence (AI) camp of its kind, free of charge, to high school students in Philadelphia. Application
GlobeNewswireCSL Joins Accumulus Synergy to Drive Industry Change
Following the launch of Accumulus Synergy’s innovative cloud-based information exchange platform, CSL joins the nonprofit industry associationBURLINGAME, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”), and its Founding Sponsors are proud to welcome CSL as its first member organization. This collaboration marks significant progress in collectively bringing together industry stakeholders to advance the mission of dramatically accelerating critical therapies to cit
